Back
ESC Premium Access

Renal function and use of medication preceding new-onset atrial fibrillation - results from the nationwide FinACAF study

Session: Atrial fibrillation e-posters
Topic: Clinical
Speaker: Miss H. Jyrkila (Helsinki, FI)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Miss Heini Jyrkila

Helsinki University Hospital, Helsinki (Finland)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Access
Abstract
Slides
Like
Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Access
Abstract
Slides
Like
Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Beirut, LB)

Access
Abstract
Slides
Like
Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Miss H. Jyrkila, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources